News
Genmab A/S (NASDAQ: GMAB) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On July 8, Truist ...
Truist also cut its 2026 free cash flow estimate by 11%, citing the lingering effects of program charges. The firm now ...
The Kiplinger Dividend 15 are poised to benefit as falling interest rates lure investors back to dividend-paying stocks.
StockStory.org on MSN10d
Red Rock Resorts (RRR) Stock Trades Up, Here Is WhyWhat Happened? Shares of casino resort and entertainment company Red Rock Resorts (NASDAQ:RRR) jumped 3.3% in the morning ...
UBS raised Texas Instruments’ price target to $255, keeping a Buy rating amid strong semiconductor demand in automotive and ...
Shares of aerospace and defense technology solutions provider Astronics Corporation (NASDAQ:ATRO) fell 3% in the afternoon ...
Astronics (ATRO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...
Truist Financial's price/earnings multiple has de-rated, with shares now trading for around 10.9x 2025 consensus EPS. Find out why I upgrade TFC shares to buy.
The new adaptive power mode added with the iOS 26 beta uses AI to trim your phone's battery usage, but it's limited to newer iPhones. Here's which ones can run it.
TruBridge, Inc. (NASDAQ:TBRG), a healthcare technology and services company, today announced that management will participate in the Truist Securities Health ...
The upgrade of Oshkosh (OSK) to 'Buy' by Truist Securities on June 3, 2025, with a price target increase to $127, reflects bullish sentiment in the industrial sector.
According to Stock Talk (@stocktalkweekly), Truist Securities has upgraded Oshkosh (OSK) to 'Buy' from 'Hold,' raising the price target to $127 from $93. Analyst Jamie Cook highlighted that OSK is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results